Pas n1 T cell epitope based peptide vaccine (Cooperative Research Centre for Asthma and Airways.)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePas n1 T cell epitope based peptide vaccine (Cooperative Research Centre for Asthma and Airways.)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccineDiagnostic agent (In vivo)
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCooperative Research Centre for Asthma and Airways
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCooperative Research Centre for Asthma and AirwaysAustralian Research Network
Active IndicationsN/A
Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A